• PDF: Delivered by email usually within 48 UK business hours.

Myeloproliferative Disorders Global Clinical Trials Review
Q2, 2011

  • Publication Date:June 2011
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:69

Myeloproliferative Disorders Global Clinical Trials Review Q2, 2011

Summary

GlobalData's clinical trial report, "Myeloproliferative Disorders Global Clinical Trials Review, Q2, 2011" provides data on theMyeloproliferative Disorders clinical trial scenario. This report provides elemental information and data relating to the clinical trials onMyeloproliferative Disorders. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treatingMyeloproliferative Disorders. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
  • Myeloproliferative Disorders
  • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
  • Top Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Myeloproliferative Disorders
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
  • Top Companies Participating in Myeloproliferative Disorders Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
  • Clinical Trial Overview of Top Companies
  • Vion Pharmaceuticals, Inc.
  • Clinical Trial Overview of Vion Pharmaceuticals, Inc.
  • Chimeric Therapies Inc.
  • Clinical Trial Overview of Chimeric Therapies Inc.
  • KaloBios Pharmaceuticals, Inc.
  • Clinical Trial Overview of KaloBios Pharmaceuticals, Inc.
  • Kiadis Pharma B.V.
  • Clinical Trial Overview of Kiadis Pharma B.V.
  • S*BIO Pte Ltd
  • Clinical Trial Overview of S*BIO Pte Ltd
  • Cell Medica Limited
  • Clinical Trial Overview of Cell Medica Limited
  • Synta Pharmaceuticals Corp.
  • Clinical Trial Overview of Synta Pharmaceuticals Corp.
  • EntreMed, Inc.
  • Clinical Trial Overview of EntreMed, Inc.
  • Incyte Corporation
  • Clinical Trial Overview of Incyte Corporation
  • Astex Therapeutics Limited
  • Clinical Trial Overview of Astex Therapeutics Limited
  • Exelixis, Inc.
  • Clinical Trial Overview of Exelixis, Inc.
  • Cell Therapeutics, Inc.
  • Clinical Trial Overview of Cell Therapeutics, Inc.
  • Novartis AG
  • Clinical Trial Overview of Novartis AG
  • Seattle Genetics, Inc.
  • Clinical Trial Overview of Seattle Genetics, Inc.
  • Eli Lilly and Company
  • Clinical Trial Overview of Eli Lilly and Company
  • Genzyme Corporation
  • Clinical Trial Overview of Genzyme Corporation
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals
  • Fred Hutchinson Cancer Research Center-Technology Transfer
  • Clinical Trial Overview of Fred Hutchinson Cancer Research Center-Technology Transfer
  • The University of Texas M. D. Anderson Cancer Center
  • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
  • Sidney Kimmel Comprehensive Cancer Center
  • Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center
  • Case Comprehensive Cancer Center
  • Clinical Trial Overview of Case Comprehensive Cancer Center
  • The University of Chicago
  • Clinical Trial Overview of The University of Chicago
  • Mayo Clinic
  • Clinical Trial Overview of Mayo Clinic
  • City of Hope National Medical Center
  • Clinical Trial Overview of City of Hope National Medical Center
  • Stanford University
  • Clinical Trial Overview of Stanford University
  • H. Lee Moffitt Cancer Center & Research Institute
  • Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute
  • Vanderbilt-Ingram Cancer Center
  • Clinical Trial Overview of Vanderbilt-Ingram Cancer Center
  • Baylor College of Medicine
  • Clinical Trial Overview of Baylor College of Medicine
  • Memorial Sloan Kettering Cancer Center
  • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
  • Masonic Cancer Center
  • Clinical Trial Overview of Masonic Cancer Center
  • OHSU Knight Cancer Institute
  • Clinical Trial Overview of OHSU Knight Cancer Institute
  • UNC Lineberger Comprehensive Cancer Center
  • Clinical Trial Overview of UNC Lineberger Comprehensive Cancer Center
  • University of California, San Francisco
  • Clinical Trial Overview of University of California, San Francisco
  • University of Medicine and Dentistry New Jersey
  • Clinical Trial Overview of University of Medicine and Dentistry New Jersey
  • Roswell Park Cancer Institute
  • Clinical Trial Overview of Roswell Park Cancer Institute
  • Wake Forest University
  • Clinical Trial Overview of Wake Forest University
  • Northside Hospital, Inc.
  • Clinical Trial Overview of Northside Hospital, Inc.
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • List of Tables
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials by Zone, 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Asia-Pacific ,Top Countries, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Europe, Top Five Countries, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, North America, Top Countries, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Central and South America, Top Countries, 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials by Phase, 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Suspended Clinical Trials, 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Withdrawn Clinical Trials, 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Terminated Clinical Trials, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Vion Pharmaceuticals, Inc., 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Chimeric Therapies Inc., 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by KaloBios Pharmaceuticals, Inc., 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Kiadis Pharma B.V., 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by S*BIO Pte Ltd, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Medica Limited, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Synta Pharmaceuticals Corp., 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by EntreMed, Inc., 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Incyte Corporation, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Astex Therapeutics Limited, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Exelixis, Inc., 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Cell Therapeutics, Inc., 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Seattle Genetics, Inc., 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center-Technology Transfer, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lee Moffitt Cancer Center & Research Institute, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by OHSU Knight Cancer Institute, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by UNC Lineberger Comprehensive Cancer Center, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials Market, Global, Clinical Trials by Northside Hospital, Inc., 2011*
  • List of Figures
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials by Zone (%), 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials by Top Countries, 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, North America, Top Countries (%), 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials by Phase (%), 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011*
    • Myeloproliferative Disorders Therapeutics Market, Global, Clinical Trials by Trial Status, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Global, Key Sponsors, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011*
    • Myeloproliferative Disorders Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011*
    • GlobalData Methodology
+44 20 8816 8548

Ask a question about Myeloproliferative Disorders Global Clinical Trials Review

Enter the characters you see in the picture below
Captcha